Aptose Biosciences
APTO
#10464
Rank
S$5.66 M
Marketcap
S$2.22
Share price
0.00%
Change (1 day)
727.10%
Change (1 year)

Aptose Biosciences (APTO) - Cash on Hand

Cash on Hand as of March 2025 : S$6.09 Million

According to Aptose Biosciences's latest financial reports the company has S$6.09 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aptose Biosciences - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$12.21 M-80.59%
2022-12-31S$62.95 M-41.15%
2021-12-31S$0.10 B-33.93%
2020-12-31S$0.16 B23.05%
2019-12-31S$0.13 B511.96%
2018-12-31S$21.5 M40.66%
2017-12-31S$15.28 M33.02%
2016-12-31S$11.49 M-43.06%
2015-12-31S$20.18 M
2014-05-31S$35.12 M4307.97%
2013-05-31S$0.79 M99.28%
2012-05-31S$0.39 M-65.2%
2011-05-31S$1.14 M-6.05%
2010-05-31S$1.22 M-84.23%
2009-05-31S$7.75 M-39.99%
2008-05-31S$12.92 M4.16%
2007-05-31S$12.4 M3.85%
2006-05-31S$11.94 M-58.38%
2005-05-31S$28.69 M-14.21%
2004-05-31S$33.44 M5.84%
2003-05-31S$31.6 M-28.57%
2002-05-31S$44.24 M-23.02%
2001-05-31S$57.47 M-12.19%
2000-05-31S$65.44 M4197.8%
1999-05-31S$1.52 M-69.6%
1998-05-31S$5 M-49.78%
1997-05-31S$9.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Advaxis
ADXS
S$6.33 M 3.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
S$0.15 B 2,380.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
S$0.78 B 12,783.72%๐Ÿ‡บ๐Ÿ‡ธ USA